JFIFC   (1#%(:3=<9387@H\N@DWE78PmQW_bghg>Mqypdx\egcC//cB8Bcccccccccccccccccccccccccccccccccccccccccccccccccc#4" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?e^5MhsKqr\94EQx0 /jO2I8@gceSD$nJzbKE sDsF-?Z$v4n8P,5=xӐ΃YSK}(ĆS/_g~A1`(_WjH$1KCmWh[i;?IWi[piǸ}lW/-1?_n܊abа-@Gzx_ib1X=?M!or9j,{,n?GzHUZ1S^MZuU[*/Ns~|XPl8!8no7FXAܳir Td?Th||vqG')ybw?/he}N8zկQq?M[`\hj]Ia'%-){Pd^O 8])㴧j'Id@'X%db@p8Tw7+*@֯?G>hT\||Bhe;j=6KuXrs un(Y(7q@ItXGl'w~T5,I]mma%`?x9Kٿarݵ[ pD^!MXt|$և/ [yFT)~AJ+}2UUYbw.9-Nu6ę ~l;nm=yJ:++HV8TS0|QE\N’6~cc8P5J>b[alb}+jʠC zVl1qf'֤EżT_ y*__Zۋ"HHPboҪs>UyϠhVjcWl0n2TP'S>X^UVaǜ{խNGmvI;jRX`:M5՜*:/jQ7oi"iVUؒ6?5 6gi0zA2@$sdLDTUgy64vP4R4bOcty~C#C})xDdRbFbhqHFh  Ցr1.[r)1i8f典';zY Xnj*|@4BhV`v=[($d`HhRv47]lQT֮uyZ* Z3jO;k}>{oǮjs>+o,R/Ͻ8`FQT̂6vƯ(=s^ ."/5o£3HnNe-ԫd9 8>ǨEIJvqp,Q955[;;`42sqª7r=Q%לzdu[Np=Eh2ͷ[6.v~˘`22x{VƋz:һcv*<`Է aJf(ǜi_"Gv:=rW$}L5=̚ۻ֫躜zk+r=hZ6=סP;:$E̮yLW|5y%ţ<7#<\\t@.G=FI?JiWDk.q\tk[Ii't#9Ubzyl|A#sTK_J'+w;#Ej3.W?yz' RXoTlV¶ $< AA4&N♏\֏E~n\e}֥"g|q2V})"}HK_*e}SqҊ]AwNhxvդ-TZ=:F*45ۭ֭o. U: ;dԝH3d#ԓ~ ma3h^sbVkFiIzUHԘly=j=@ybWЎzFn<:}i7gQڽhJG)ʫ% ַƶ5=^;*:h>q\K" =c -oq,á;k{j\aNB h-g#tuEA$n^wz[n,2JH5ǿ& (Zlu nu%Nn4=re&s}¨Vi3\L럝 =0x͘h0i_ʝ \[K9ՖA7Z Ygy |I¹Y?ZJ:W0˕w-^kU,I=]D11C, ։ʬRL }x;4a0,O͌ .4"X$b1*~E'-`yd'8) ڦ~ H3\j%a@;f"RA0N:RX >h՝U*w)-w{)jL+\LQaLD&>*KTJNeZB]󱎂E4 !u=?x* Q~f'G^yy_dU.YjNsU$z0 IsP/9ޭ<%"f^0.5LU X0CL1 da~1'GBW9MmZG}1/sZⵛJx^c@Y2j\%;e1/D'%}itB49Hb^Lkr|5y9Uom%ˑ0,pzM.蚔ZUۼA#TYH!x9ϻ66 M?jzf:}{YX-jKO%c!E =ץKH'cyy_B9uQ[M- c*9+'#54#mΓ5wd`>`*xMK+$(wE$Xİ3 >g:5Z-c{`#>OSK}@ {\kC2Yw` Q_$'i<7Oy' 土-Ռjے?H4_dNEBr3Y4bSGԷ}ʳ[~~M!vE[kT~bqSiP+47$RJIG lDyOOҨYJmW8l!^?ݘSԋE Zsȩ"ȫ<:SLuqL1{RgTlTLMs1G"`zTCE6ZhNjvZI \0[ OfϿg_+U/r`UX̝j;sެ\vz桂#qt/F v6]+:mXHjƮEe?pԺLBnw'yKCf޲~x Z)r*P\ZӔ +=4&zl5(' ޮ"ېUϚH? ~O$bO9aFUY66̐>խ/wE/4; ?]OQ.Td8,\U+x,HL&AFƒOPH5%vI#̓ܟUGurx_rjޯloSc{}FъnV!GfscNh N ;F;>S<ȁImhU]UXY]_XqZ\%2)R8.zӸXҤovyYBT\dpԞ'__ΛvT`<>#oe>֗X;jqyS1\,)ȥwid291ɩeotlnuסFթ9^WL jb*) XjeԱDM[{TܢSZVңڐ\Œ!U$&*Ɍ&cq^*Uqޭ2Uמ]*.GJEQr; s-:G#}I`(܌VbP۹L63NXM@ >M=r=ɓPcYJI-/ @vbQQfO|)3S 1 os&GQ먠ӣ8iWnv' cli(H-=Tu4OSؗV\A}c{x&EN0T}ii%=Hz%PIc֠v3JğuG>kO6d5Hogp A~rO@X pb=Yƣj PvMy8#{ҕ܅Oz0Y+ocm'm{?6Q5Q'Cgݧݷp{~5H͹)` \,gAqa0[Su>u#6;GUms 2!`D4L0qzԫ_hm;şI) +3R4t}FjrMuGjT61&JOң@=XDAz8G$LYԸhLIҭU &Ved\ 7Z?VA\ KNu님 w(_~T7@El3{~?=8r89H7ڟ jjUrf_5dڝ{Tj0jECi*E\(8HC v0pbj^Ԕu1E;(֪SZ.H1>TM?:aL=IeTw'4UڧZDD5[iF9FMR('Ÿ"U'$OJl_=E)lԳj\ݵv!] l|5ls=*X@'$lqPg[H&8.p81E㚔/ũ@8PQP!ԸjOh41/ҁ;o)q< u;м:&KF`sܤv4_P*iNZz["51DCGJv k6R%ZI<1hYR}i۽꺓KzO7\IZcj(?xTmr5Vy%5 MWkjHl&k?Λ&'֣$wFNNvF=sMXmܝF-~@f{xy$JKAȢB]8Q+e/sAYӂ.sUn{լ`J7`N Е1ަSP"QR)4FFzSG(Ӳ)} 4Ѷ`wʯR)d41J0JJOZ_9)>sNzUS4:rp+2}P>0ֱDNx5z >9mrKd<̌t4ų>jU5-!p kSA"0; M!=)$=Izp5 `cթU6DaLw)ʘ@2z QS3sQsVhbzPcSVIАOpMHXB.A膞-2je QJ_Μ$?V1K@"nO\w"FLrZoy|MҊC#Ke'&X^4FH*&942P3NQ0Sց s܆=ePNi킄{U;)|@4tD)9:)IsFh8pKL3HdHcgҘ͎IP$;Tm w{dUrC!&f;њK"-ɦ{TI=)BPIڍMlv!j,~04{0+jeсz[Qy-Eo{yuڢrث^`cuDYRF'5,Dr=ʅ&28m0 V85 R@ZB) p) zөq@@})PjQ@i `#4((=4zS"Ie˻ȫqj,ivIvy\L2{z HcB=i:х}irzԼzSwJ3gM)>ԿL7"9Xq4bn( bXfH@!<5I,cju@xgn)-r>~^>ӑ_72 9@DJ0`>vOVYsRBvu;Ur+׊xe%SB/$ ֟(@#9k|jYCE&"a֐`j9&})f@0P^1GQNU3y+ xѳsV϶~$NJl!aAdԕq14Rb 9t8A 6Sr*Hy9'&Hs89I }~)Ig!ia_S-z>N_w=qEn3{(}H1R?iZ˫4xW2b U+2F䚴* JײU({ |/=$`PS`L~ryq*ͺF^i`DnQSRg Qaܝ^6j@q,ދ`RT }7ҕpiCbD>&JD#1޳gUzUKk 8*jDg#hc-=i-owM-L)7Q`y&H@i~Tnj@&3M4nAjG&F;RgB4o"$*a@3fj"i- E->&=hosN͟1$PZbv@~ݚl*};{UB->Olj :88~7g֥9u\e3@wDJRS:/'w  "݋;υTfT*arA \J>{lf~/R8 cGMG[=X4;;;4Rd▣ ay'%/Z;II"w;vL'FzSIOjeH>Rތ]?֊lf/Ϸ8N mpTSA<Z-Yjn# Ӛpۛ#i=։sI֜@ۏZZ=3^'oaj8G+b Lv(wu`88z3zjf!*2K:Bth>mEvt4@'qHe}4i,YKfK(AN5Fm3B7AЊPAb?#IP/T}FO:_~3LZH$`q@3zNU5`c$M!\t 5,N87vȤEHf ET ݤՒOVCz4=EVsO' i2i"!i{SA4(qN" )JA4LgA8$<i:Ri3@!Ci-KE-}I<[-PR+ӳrE 3Wԑ?*6PjbeU H dF1Ȝ pՑ3yHvzV6"+P)Z4Ǎ |K zh\b3 HMIj-<:d]2dz ()ғ@ E12HHM&yMc?XST-@~uScf%͕cl?.Eh搓M6K3Gˏjb$ĄҮ(~1ց.iǐ;ՁyEjFmutRN*f0n/=YѪCuFl۳FUZh4泼8PL:_2:~6)X&YQ#jts-K;T/ނuۑR3o(')3bpS5,@IɡJL0av95,1'4ass'֊.n\[&ZA;úZaq]ǟUug/_ƥ8GG~a*{ GS+U{GF 3Zd(qxL)Jgnֆ1mQY85y[՞j~1U>\=J s# y Vd6;҇X?*e֓*mq"$2*hnK(ؕr#5:ܼbD` 4Zajdr6WCEYo?Oª]dǻҬ[oڱf=P??I | ǒ@1(e ܪG4m{zԁ`d~&- ֤[;PRQuܫFL0z$?AI&K1#!#14] o`d>Ɛ۟_V Eg7$c5n8RsB}n6'z0?7μ$#զnpjuxċk;! #bM%NqpFMzGǏV}g)wl8ֆv)}?XK~-M|{R S陎y=t3/ܷ'ݺy\`9VUܸSERUT_O1;[84v E$N:2fEQ\*h-l9zǥP!YؠRxE